Loading clinical trials...
Loading clinical trials...
Pilot Study Assessing the Feasibility of a Surgery and Chemotherapy-Only Approach in the Upfront Therapy of Children With Wnt Positive Standard Risk Medulloblastoma
Conditions
Interventions
Lomustine
Vincristine
+4 more
Locations
16
United States
Phoenix Childrens Hospital Hematology/Oncology
Phoenix, Arizona, United States
Children's Hospital Colorado Center for Cancer & Blood Disorders
Aurora, Colorado, United States
M D Anderson Cancer Center-Orlando Pediatric Hematology/Oncology
Orlando, Florida, United States
All Children's Hospital Pediatric Hematology/Oncology
St. Petersburg, Florida, United States
Children's Healthcare of Atlanta- Egleston Pediatric Neuro-Oncology
Atlanta, Georgia, United States
Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology
Chicago, Illinois, United States
Start Date
April 4, 2017
Primary Completion Date
November 9, 2018
Completion Date
November 9, 2018
Last Updated
November 5, 2021
NCT05535166
NCT07087002
NCT06898684
NCT04501718
NCT04195555
NCT04978727
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions